$125.00
Buy PNC-27, a unique peptide derived from the MUC1 protein, has gained attention for its potential properties. This peptide is designed to selectively target and disrupt cancer cell membranes, promoting apoptosis (programmed cell death) while sparing healthy cells. PNC-27 has been studied for its ability to enhance the effectiveness of conventional cancer treatments and improve overall therapeutic outcomes. Additionally, research indicates that PNC-27 may have immunomodulatory effects, potentially boosting the body’s natural defenses against cancer. As an exciting focus in cancer research, PNC-27 holds promise for developing innovative strategies to combat malignancies in research.
5mg – Lyophilized *MUST BE RECONSTITUTED*
PNC-27 is a peptide derived from the naturally occurring protein p53, which plays a crucial role in regulating the cell cycle and preventing tumor formation. This peptide has garnered significant attention for its potential applications in cancer research due to its ability to selectively induce apoptosis (programmed cell death) in cancer cells while sparing normal cells. PNC-27 is being explored for its research benefits in treating various types of cancer.
PNC-27 was developed as a potential therapeutic agent by researchers investigating the tumor-suppressing properties of the p53 protein. Initial studies demonstrated its ability to target cancer cells effectively, leading to further research into its mechanisms of action and potential applications in oncology.
PNC-27 is a synthetic peptide that consists of 27 amino acids, mimicking the structure of a specific region of the p53 protein. This unique composition allows PNC-27 to bind to and activate the p53 pathway, which is vital for regulating cell growth and apoptosis. By harnessing the natural functions of p53, PNC-27 aims to promote cancer cell death and inhibit tumor growth.
PNC-27 functions primarily by binding to the membrane of cancer cells, leading to the formation of pores that induce cell lysis. This selective action allows PNC-27 to target malignant cells while minimizing damage to healthy cells. Additionally, PNC-27 may enhance the activity of the p53 protein, promoting further apoptosis in cancerous tissues.
The ability of PNC-27 to selectively induce apoptosis in cancer cells is a key factor in its potential therapeutic use. By exploiting the vulnerabilities of cancer cells, PNC-27 offers a novel approach to cancer treatment that could complement existing therapies.
One of the most significant benefits of PNC-27 is its potential as an anti-cancer agent. Research indicates that PNC-27 can effectively induce apoptosis in a variety of cancer cell types, making it a promising candidate for further investigation in cancer therapy.
Unlike traditional chemotherapy agents, which often have broad-spectrum toxicity, PNC-27 appears to spare normal cells, reducing the side effects associated with conventional cancer treatments. This selective action is crucial for improving patient outcomes and quality of life during cancer therapy.
PNC-27 has the potential to be used in combination with other cancer treatments, enhancing their effectiveness. Its unique mechanism of action may help overcome resistance to conventional therapies, making it an exciting area of research in oncology.
What sets PNC-27 apart from other peptides is its specific targeting of cancer cells through its unique mechanism of action derived from the p53 protein. While many peptides are used for therapeutic applications in general health, PNC-27’s focused approach to inducing cancer cell death positions it as a specialized agent in cancer treatment research.
Beyond its direct anti-cancer effects, PNC-27 is being studied for its implications in understanding cancer biology and the mechanisms of tumor suppression. Research on PNC-27 may contribute to advancements in cancer therapies and the development of new treatment strategies.
The incorporation of PNC-27 into existing cancer treatment regimens may enhance therapeutic efficacy and reduce the incidence of treatment-related side effects, paving the way for more effective cancer management.
For Research Use Only
At Peptide Hub, pride in our craftsmanship is at the heart of everything we do. Our commitment to excellence and attention to detail ensure that every project we undertake meets the highest standards of quality and durability.
1-888-
Mon – Fri: 9 am – 6 pm (PST)
info@peptidehub.com
Mon – Thurs / Excluding holidays
Orders placed and paid for after 12PM PST are shipped the following business day
Irvine, CA 92602
© 2024 Peptide Hub, Inc. All Rights Reserved.
The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.